Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Oak Hill Bio

Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine
From Oak Hill Bio
Via Business Wire
Oak Hill Bio Enters into Exclusive License Agreement with Roche to Obtain Global Rights for a Phase 3-Ready, Potential Best-in-Class Treatment for Individuals with Angelman Syndrome
From Oak Hill Bio
Via Business Wire
Oak Hill Bio and Chiesi Group Announce First European Patient Enrolled in the Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants
From Oak Hill Bio
Via Business Wire
Oak Hill Bio Announces Promotion of Josh Distler to Chief Executive Officer and Additional Updates to Executive Team and Board
From Oak Hill Bio
Via Business Wire
Oak Hill Bio and Chiesi Group Announce First Patient Enrolled in the Resumed Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants
From Oak Hill Bio
Via Business Wire
Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialize OHB-607, a potentially transformative neonatal therapy
From Oak Hill Bio
Via Business Wire
Oak Hill Bio to Participate in Citi 17th Annual BioPharma Conference
From Oak Hill Bio
Via Business Wire
Oak Hill Bio to Participate in 2022 Wells Fargo Private Biotech Symposium
From Oak Hill Bio
Via Business Wire
Oak Hill Bio Sponsors Industry Symposium at International Conference on Clinical Neonatology
From Oak Hill Bio
Via Business Wire
Oak Hill Bio Appoints Tauhid Ali as First Chief Executive Officer
From Oak Hill Bio
Via Business Wire
Oak Hill Bio to Present at 2022 RBC Capital Markets Global Healthcare Conference
From Oak Hill Bio
Via Business Wire
Oak Hill Bio Announces Formation of Board of Directors
From Oak Hill Bio
Via Business Wire
Oak Hill Bio Launches With Pipeline and Senior Leadership From Takeda
From Oak Hill Bio
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.